Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis

Iyad Alnahhas, Mohammad Jawish, Mouaz Alsawas, Alicia Zukas, Larry Prokop, Mohammad H Murad, Mark Malkin

Research output: Contribution to journalArticle

2 Scopus citations


While primary central nervous system lymphoma is sensitive to methotrexate chemotherapy, more than half of patients will experience relapse within 5 years. Autologous stem-cell transplantation (ASCT) is increasingly used as consolidative treatment. This systematic review and meta-analysis provides estimates response and survival after ASCT and suggests improved rates compared to the historical data.

Original languageEnglish (US)
JournalClinical Lymphoma, Myeloma and Leukemia
StateAccepted/In press - Jan 1 2018



  • Conditioning chemotherapy
  • Consolidation
  • Induction chemotherapy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this